Watts, Nelson B.
Article History
First Online: 22 April 2014
Competing interests
: N.B.W. is co-founder, stockholder and director of OsteoDynamics; has received honoraria for lectures from Amgen and Merck in the past year; has received consulting fees from AbbVie, Amarin, Amgen, Bristol–Myers Squibb, Corcept, Endo, Imagepace, Janssen, Lilly, Merck, Novartis, Noven, Pfizer/Wyeth, Radius and Sanofi-Aventis in the past year; and, through his Health System, has received research support from Merck and NPS Pharmaceuticals.